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Background: Aortic valve stenosis (AS) is the most common valvular heart disease in elderly people. Detection of high-risk patients is an 
important issue for the management of AS patients. Previous studies have shown that plasma levels of BNP increases with AS severity and may 
provide prognostic information. However, these studies were impeded by selection bias and inclusion of relatively young patients, or their small 
sample sizes. Thus, the aim of the present study was to evaluate the prognosis value of BNP in a prospective cohort of elderly patients with AS.
Methods: Nt-proBNP was measured at entry in the study and patients were prospectively followed on a yearly basis. Inclusion criteria were age 
≥ 70 years, at least mild AS (mean gradient ≥ 10 mm hg), absence of symptoms, normal left ventricular function and absence of significant renal 
insufficiency (creatinine clearance < 30 ml/min).
Results: Three hundred and forty six patients were included. Mean age was 79±6 years. Two hundred and twenty five had severe AS (valve area 
< 1cm2) and 196 were symptomatic. BNP increases with NYHA class and hemodynamic parameters (p<0.0001). However, Nt-proBNP values were 
widely scattered with a large overlap between symptomatic and asymptomatic patients. Consequently, Nt-proBNP had poor sensibility and specificity 
for the detection of patients with severe symptomatic AS (ROC curve=0.73, sensitivity=47%, specificity=85%, cut off Nt-proBNP value of 737pg/ml). 
Among the 150 asymptomatic patients, 12 underwent a prophylactic surgery and follow-up was in 126 (91%). Patients with NT-proBNP < 300 pg/ml 
had a better outcome than patients with Nt-proBNP between 300 and 700pg/ml, or > 700pg/ml (99% vs. 90% and 86% event free survival at one 
year, p=0.004). However, Nt-proBNP was not an independent predictor of outcome after adjustment for valve area, age and gender (p=0.30).
Conclusion: Our study is the first to enhance the limits of Nt-proBNP for the evaluation of AS patients. Our data show that Nt-proBNP is not an 
independent prognostic factor of outcome and raises caution regarding a patients’ management based on BNP value especially in the elderly 
population.
